Summary
Background Current colorectal surveillance guidelines emphasize adenoma characteristics but overlook temporal, racial, and sex-based heterogeneity in recurrence risk— an gap that limits equitable and personalized care. To evaluate the associations of demographic factors, obesity, and adenoma features with recurrence risk over time in a large longitudinal surveillance cohort.
Methods This retrospective cohort study included 59,667 adults who underwent their first colonoscopic polypectomy between January 1990 and July 2024 at a tertiary medical center. Median follow-up was 4 years. Demographic variables included race and ethnicity (non-Hispanic White [NHW], non-Hispanic Black [NHB], Hispanic, Asian or Pacific Islander [API]), sex, obesity (BMI >30), family history of colorectal cancer (CRC) or polyps, and age at adenoma onset (<50 vs ≥50 years). Adenoma features included histology, size, number, and dysplasia. The primary outcome was recurrence-free survival, defined as time from initial polypectomy to histologically confirmed recurrence. Cox proportional hazards models estimated associations adjusted for confounders, with stratified analyses over 5-, 10-, and >10-year follow-up intervals.
Findings Among 59,667 patients, 17,596 (29.5%) experienced recurrence within 5 years, revealing substantial temporal heterogeneity. Early recurrence was associated with male sex (adjusted hazard ratio [aHR], 1.10; 95% CI, 1.06–1.14), obesity (aHR, 1.18; 95% CI, 1.13–1.23), early-onset adenomas (aHR, 1.17; 95% CI, 1.11–1.23), and family history of CRC (aHR, 1.24; 95% CI, 1.18–1.31). Compared with NHW patients, NHB individuals had lower early recurrence risk (aHR, 0.89; 95% CI, 0.83–0.96) but higher late recurrence (>10 years; aHR, 1.26; 95% CI, 1.06–1.50). API patients had a similar shift, with lower early risk (aHR, 0.80; 95% CI, 0.67– 0.96) and elevated mid-term risk (5–10 years; aHR, 1.40; 95% CI, 1.08–1.81). High-grade dysplasia (aHR 2.86; 95% CI, 2.54–3.22) and villous histology (aHR 2.55; 95% CI, 2.31–2.81showed the largest effect sizes for early recurrence. Females had stronger associations with tubulovillous histology, mixed adenomas, and large lesions.
Interpretation Temporal, demographic, and histologic differences in adenoma recurrence highlight the need for surveillance strategies that incorporate population- and time-specific risk profiles to enhance colorectal cancer prevention.
Funding This work was supported by the National Cancer Institute (Grant No. R37CA227130 to Xingyi Guo).
Evidence before this study We conducted a PubMed search for publications dated before June 2024 using combinations of keywords such as “colonoscopic polypectomy,” “Demographic and Clinicopathologic Risk Factors,” “Vannderbilt,” and “electronic health records.” We found no studies that comprehensively evaluated the associations of demographic characteristics, obesity, and adenoma features with recurrence risk over time in a large, longitudinal surveillance cohort.
Added Value of This Study Using a longitudinal cohort of 59,667 patients, our study reveals substantial temporal heterogeneity in adenoma recurrence. Non-Hispanic Black and Asian or Pacific Islander individuals exhibited a lower risk of recurrence within the first 5 years but experienced increased risk at 5–10 and >10 years post-polypectomy. Females showed heightened early recurrence risk, particularly when initial adenomas were tubulovillous, mixed-type, or large. Early recurrence was predominantly driven by high-grade dysplasia, high-risk adenomas, villous or tubulovillous histology, and multiplicity.
Implications of All the Available Evidence These findings highlight the critical need to recognize and address temporal, racial, and sex-specific heterogeneity in adenoma recurrence risk. The observed variability in histopathologic and demographic factors over time underscores the importance of personalized, adaptive surveillance strategies to reduce adenoma recurrence and enhance colorectal cancer prevention.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed and exempted from human subjects' research by the Institutional Review Board at Vanderbilt University Medical Center (IRB #250158). Patient confidentiality was maintained through data de-identification, and all procedures adhered to relevant ethical standards. Data was stored and analyzed in a secure, encrypted, access-controlled database.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Cox proportional hazards models estimated associations adjusted for confounders, with stratified analyses over 5-, 10-, and >10-year follow-up intervals. The results have been updated based on this new analysis.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
